NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 00517-6202-25 — Trace minerals (copper, manganese, zinc) IV solutionAI (237 hospitals, 55,151–56,069 samples)
• NDC 00074-4378-05 — Cisatracurium 2 mg/mL intravenous injectionAI (284 hospitals, 54,286–56,068 samples)
• NDC 63323-0462-04 — Bupivacaine with epinephrine injection (preservative-free)AI (264 hospitals, 55,047–56,046 samples)
• NDC 14789-0250-07 — Ephedrine 5 mg/mL solution, 10 mL vialAI (317 hospitals, 54,815–56,039 samples)
• NDC 00143-9787-01 — Enalaprilat injection, 1.25 mg/mLAI (524 hospitals, 54,990–56,034 samples)
• NDC 83490-0307-60 — 7% saline solution for nebulizer treatmentAI (303 hospitals, 54,949–56,020 samples)
• NDC 63323-0086-05 — Potassium phosphate IV solutionAI (347 hospitals, 54,983–56,009 samples)
• NDC 42571-0265-75 — Nitroprusside 25 mg/mL solution, 2 mL vialAI (165 hospitals, 55,091–56,000 samples)
• NDC 00143-9532-01 — Dexmedetomidine 200 mcg per 2 mL nasal medicationAI (218 hospitals, 54,782–55,997 samples)
• NDC 00378-8270-52 — Albuterol sulfate 2.5 mg/3 mL nebulizer solutionAI (209 hospitals, 54,782–55,997 samples)
• NDC 70860-0784-41 — Valproate sodium intravenous injection, 500 mg per 5 mLAI (218 hospitals, 54,971–55,997 samples)
• NDC 00409-6695-02 — ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTIONAI (416 hospitals, 54,769–55,993 samples)
• NDC 23155-0345-33 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSIONAI (206 hospitals, 53,941–55,984 samples)
• NDC 00378-8270-31 — Albuterol nebulizer solutionAI (266 hospitals, 54,791–55,979 samples)
• NDC 00264-7578-10 — MANNITOL 20 % INTRAVENOUS SOLUTIONAI (349 hospitals, 54,939–55,965 samples)
• NDC 63323-0690-30 — Acetylcysteine 20% solution, 30 mL vialAI (840 hospitals, 54,932–55,949 samples)
• NDC 00409-1144-65 — Verapamil 2.5 mg/mL IV injectionAI (208 hospitals, 54,866–55,946 samples)
• NDC 63323-0460-37 — Bupivacaine with epinephrine numbing solution, 30 mL vialAI (386 hospitals, 54,883–55,936 samples)
• NDC 17238-0900-99 — Fluorescein eye test stripsAI (436 hospitals, 54,930–55,929 samples)
• NDC 00378-9671-93 — Ipratropium-albuterol nebulizer solutionAI (449 hospitals, 54,787–55,921 samples)
• NDC 70860-0605-41 — Dexmedetomidine 100 mcg/mL IV solutionAI (179 hospitals, 54,929–55,919 samples)
• NDC 00781-3150-75 — Cisatracurium injection, 2 mg/mLAI (197 hospitals, 54,929–55,919 samples)
• NDC 00703-2033-01 — Cisatracurium injection, 10 mg per 5 mLAI (153 hospitals, 54,929–55,919 samples)
• NDC 00009-0342-01 — Absorbable porcine gelatin sponge for topical useAI (318 hospitals, 54,951–55,914 samples)
• NDC 00409-9042-16 — Bupivacaine with epinephrine, preservative-free 0.25% injectionAI (141 hospitals, 54,889–55,897 samples)
• NDC 00093-6816-73 — Budesonide 0.5 mg/2 mL inhalation suspensionAI (483 hospitals, 54,769–55,867 samples)
• NDC 69097-0840-87 — Ipratropium and albuterol nebulizer solutionAI (186 hospitals, 54,769–55,867 samples)
• NDC 69097-0840-64 — Ipratropium and albuterol nebulizer solutionAI (142 hospitals, 54,768–55,857 samples)
• NDC 69097-0840-53 — Ipratropium and albuterol nebulizer solutionAI (158 hospitals, 54,768–55,857 samples)
• NDC 00378-8270-91 — Albuterol sulfate 2.5 mg nebulizer solutionAI (109 hospitals, 54,767–55,847 samples)
• NDC 51754-2001-04 — Potassium acetate injection, 2 mEq/mLAI (593 hospitals, 54,921–55,839 samples)
• NDC 17478-0045-32 — Tetracaine 1% numbing solution, 2 mL ampuleAI (453 hospitals, 54,800–55,835 samples)
• NDC 00409-9558-11 — Rocuronium injection, 10 mg/mLAI (248 hospitals, 54,790–55,834 samples)
• NDC 00186-1988-04 — Pulmicort inhalation suspension, 0.25 mg per 2 mLAI (359 hospitals, 54,823–55,831 samples)
• NDC 63402-0911-30 — Arformoterol nebulizer solution, 15 mcg per 2 mL vialAI (410 hospitals, 54,765–55,827 samples)
• NDC 51754-0203-01 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (266 hospitals, 54,834–55,824 samples)
• NDC 00409-4011-61 — Verapamil hydrochloride 2.5 mg/mL intravenous solutionAI (94 hospitals, 54,804–55,821 samples)
• NDC 00143-9318-01 — Norepinephrine intravenous solutionAI (276 hospitals, 54,803–55,820 samples)
• NDC 43598-0587-23 — Sodium nitroprusside intravenous solutionAI (291 hospitals, 54,821–55,820 samples)
• NDC 00143-9234-01 — Vecuronium bromide injectionAI (165 hospitals, 54,919–55,819 samples)
• NDC 00990-7936-19 — Dextrose 50% sugar solution for injectionAI (305 hospitals, 54,909–55,809 samples)
• NDC 59365-6065-00 — Ferric subsulfate 259 mg/g solution, 8 g bottleAI (431 hospitals, 54,782–55,808 samples)
• NDC 00378-9671-31 — Ipratropium-albuterol nebulizer solution, 3 mLAI (345 hospitals, 54,775–55,801 samples)
• NDC 54288-0127-10 — Tetracaine 1% injectable solutionAI (389 hospitals, 54,418–55,795 samples)
• NDC 25021-0682-20 — KETAMINE 10 MG/ML INJECTION SOLUTIONAI (345 hospitals, 54,099–55,791 samples)
• NDC 70756-0612-70 — Arformoterol 15 mcg/2 mL nebulizer solutionAI (182 hospitals, 54,761–55,787 samples)
• NDC 00409-3299-06 — Sodium acetate intravenous solutionAI (311 hospitals, 54,849–55,785 samples)
• NDC 55150-0439-10 — Ketamine 50 mg/mL injectionAI (291 hospitals, 54,631–55,783 samples)
• NDC 63323-0321-10 — Polymyxin B sulfate injection, 500,000-unit vialAI (317 hospitals, 54,760–55,777 samples)
• NDC 69097-0319-32 — Budesonide 0.5 mg/2 mL nebulizer solutionAI (285 hospitals, 54,760–55,777 samples)